B-I files MAA to expand EU Pradaxa label to include acute treatment and secondary prevention of VTE: http://in.reuters.com/article/2013/06/24/us-boehringer-pradaxa-idINBRE95N0K820130624 No indication that a similar application has been filed with the FDA; in the US, Pradaxa is approved only for AF/stroke prevention.